Results of using the neuroprotective drug Cellex in non-traumatic intracranial hemorrhage
Introduction. In the Russian Federation, neuroprotective agents are widely used in the treatment of patients with ischemic stroke. There are accumulated data on the efficacy and safety of the neuroprotective agent Cellex® in ischemic stroke. The use of this drug in hemorrhagic stroke has been studie...
Hlavní autoři: | Kh. D. Mongush, A. V. Kyrgys, A. A. Sedip, A. E. Shyyrap, A. B. Ondar, M. G. Zhestikova |
---|---|
Médium: | Článek |
Jazyk: | Russian |
Vydáno: |
Remedium Group LLC
2022-03-01
|
Edice: | Медицинский совет |
Témata: | |
On-line přístup: | https://www.med-sovet.pro/jour/article/view/6755 |
Podobné jednotky
-
Efficacy of Cellex in patients with mild cognitive impairment
Autor: B. A. Abusueva, a další
Vydáno: (2019-04-01) -
NEUROPROTECTION INFLUENCE ON COURSE OF CEREBRAL STROKE
Autor: G. N. BELSKAYA, a další
Vydáno: (2016-12-01) -
Neuroprotection by Ozanimod Following Intracerebral Hemorrhage in Mice
Autor: Fei Wang, a další
Vydáno: (2022-06-01) -
Drug-induced non-traumatic intracranial hemorrhage associated with the use of anticoagulants and antiplatelet agents
Autor: O. D. Ostroumova, a další
Vydáno: (2022-12-01) -
Acute albumin administration as therapy for intracerebral hemorrhage: A literature review
Autor: Yirong Cao, a další
Vydáno: (2024-01-01)